Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A machine learning model for diabetic retinopathy risk stratification using routine blood and urine parameters: insights into kidney-eye crosstalk.

Frontiers in endocrinology·2026
Same author

Ablation of idiopathic fascicular ventricular tachycardia in a patient with congenitally corrected transposition of the great arteries: A case report.

HeartRhythm case reports·2026
Same author

Nitroxyl relieves acute kidney injury by suppressing SLC31A1-mediated cuproptosis in renal tubular epithelial cells.

Life sciences·2026
Same author

A Plasmonic "Lid-Off" Nanoplatform for Spatiotemporally Controlled PA/NIR-II Dual-Modal Imaging and Cuproptosis-Based Synergistic Photothermal and Chemodynamic Therapy.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Ti@ZnO Mediated Sonodynamic Disruption of Deep Implant Biofilms with Concomitant Immune Tracestream Remodeling.

Advanced healthcare materials·2026
Same author

A Radial Modulus-Gradient Fiber for Chronic Recording and Decoding in Deep Brain.

Advanced materials (Deerfield Beach, Fla.)·2026
Same journal

HER2-mutated lung squamous cell carcinoma responding to trastuzumab deruxtecan followed by pyrotinib: a Case Report.

Frontiers in pharmacology·2026
Same journal

Awareness, attitudes, and self-reported clinical management of antimicrobial-associated neurocognitive adverse effects among healthcare providers in Saudi Arabia.

Frontiers in pharmacology·2026
Same journal

Low-dose dasatinib in second-line therapy or beyond for the treatment of chronic-phase chronic myeloid leukemia: a real-world cohort study.

Frontiers in pharmacology·2026
Same journal

Natural products reshape osteosarcoma cell fate: promoting cell death.

Frontiers in pharmacology·2026
Same journal

<i>Leonurus japonicus</i> Houtt. extract containing isoquercitrin reduces airway inflammation in mice with allergic asthma.

Frontiers in pharmacology·2026
Same journal

Enhancing diabetes treatment by targeted nucleic acid and drug delivery using cell-penetrating peptides, peptide nucleic acids, and receptor targeting.

Frontiers in pharmacology·2026
See all related articles

Related Experiment Video

Updated: Jun 14, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K

Comprehensive hepatotoxicity prediction: ensemble model integrating machine learning and deep learning.

Muhammad Zafar Irshad Khan1, Jia-Nan Ren1, Cheng Cao1,2

  • 1College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.

Frontiers in Pharmacology
|September 5, 2024
PubMed
Summary
This summary is machine-generated.

This study developed an ensemble model to predict chemical-induced liver injury, achieving 80.26% accuracy. This computational approach aids early drug development by identifying potential hepatotoxicity risks efficiently.

Keywords:
deep learningensemble modelhepatotoxicitymachine learningmolecular fingerprints

More Related Videos

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

4.3K
Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
08:25

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Published on: June 5, 2020

6.7K

Related Experiment Videos

Last Updated: Jun 14, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K
Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

4.3K
Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
08:25

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Published on: June 5, 2020

6.7K

Area of Science:

  • Computational toxicology
  • Drug discovery and development
  • Machine learning in pharmacology

Background:

  • Chemicals can cause acute liver injuries, a significant health concern.
  • Assessing compound safety is complex and costly.
  • In silico methods can identify drug candidate risks early, reducing development expenses.

Purpose of the Study:

  • To develop accurate Quantitative Structure-Activity Relationship (QSAR) models for predicting chemical hepatotoxicity.
  • To integrate machine learning (ML) and deep learning (DL) algorithms for enhanced prediction accuracy.
  • To mitigate drug development costs by enabling early identification of liver injury risks.

Main Methods:

  • Developed QSAR models for hepatotoxicity prediction using an ensemble strategy.
  • Integrated diverse ML and DL algorithms with various molecular descriptors and fingerprints.
  • Utilized feature selection and hybrid ensemble approaches for model optimization.
  • Trained models on a dataset of 2588 chemicals and drugs, divided into training (80%) and test (20%) sets.

Main Results:

  • The voting ensemble classifier achieved optimal performance with 80.26% prediction accuracy, 82.84% AUC, and over 93% recall.
  • Ensemble methods like bagging and stacking also showed strong performance.
  • The model demonstrated superior reliability compared to existing published models through external validation and cross-validation.

Conclusions:

  • The proposed ensemble model provides a reliable and high-performing method for predicting chemical-induced liver damage.
  • This approach offers a dependable assessment of hepatotoxicity risk for chemicals and drugs.
  • Facilitates early-stage risk assessment in drug development.